Kelsey Financial’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Kelsey Financial’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-42,000	Closed	-$10.4K	–	68
2026 Q1	$10.4K	Buy	42,000 +7,000	+20%	+$2.79K	0.01%	62
2025 Q4	$14.7K	Buy	+35,000	New	+$18.6K	0.01%	61

Other funds holding SGMO

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

AIM

Axiom Investment Management New York $150M AUM

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Kelsey Financial's SGMO Position: Q2 2026 in Review

Kelsey Financial sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 42,000 shares — an estimated $10.4K sold.

Kelsey Financial first reported a position in SGMO in Q4 2025 and held it in 2 quarters. The position peaked at $14.7K in Q4 2025. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Kelsey Financial reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Kelsey Financial sold 42,000 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $10.4K.
Kelsey Financial first reported a position in SANGAMO THERAPEUTICS INC in Q4 2025 and held it in 2 quarters.
Kelsey Financial's SANGAMO THERAPEUTICS INC position peaked at $14.7K in Q4 2025.
6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Kelsey Financial's 13F filing for Q2 2026, filed 10 Aug 2026.